Trump Announces Drug Pricing Deal, Then Naps

President Trump announced a significant deal with drug manufacturers to lower drug prices, representing 86% of the branded pharmaceutical market in the US. He outlined three key objectives moving forward: negotiating with the remaining 14% of the market, continuing international negotiations, and working with Congress to codify these policies. The president emphasized the importance of American innovation and exceptionalism in ensuring affordability and future progress.